[5'-O-DMTr-2'-OMe-A(Bz)](pCyEt)[2'-OMe-A(Bz)](pCyEt))[2'-OMe-A(Bz)-3'-CE-Phosphoramidite]
[5'-O-DMTr-2'-OMe-A(Bz)](pCyEt)[2'-OMe-A(Bz)](pCyEt))[2'-OMe-A(Bz)-3'-CE-Phosphoramidite] - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.OP-332
-
SMILESO=P(OCCC#N)(OC[C@H]1O[C@@H](N2C(N=CN=C3NC(C4=CC=CC=C4)=O)=C3N=C2)[C@H](OC)[C@@H]1OP(OCCC#N)(OC[C@H]5O[C@@H](N(C=N6)C7=C6C(NC(C8=CC=CC=C8)=O)=NC=N7)[C@H](OC)[C@@H]5OP(OCCC#N)N(C(C)C)C(C)C)=O)O[C@H]9[C@@H](OC)[C@H](N%10C(N=CN=C%11NC(C%12=CC=CC=C%12)=O)=C%11N=C%10)O[C@@H]9COC(C%13=CC=CC=C%13)(C%14=CC=C(OC)C=C%14)C%15=CC=C(OC)C=C%15
-
Molecular FormulaC90H96N19O22P3
-
Molecular Weight1888.7903
-
AppearanceWhite to off-white solid
-
PurityUPLC≥97%
-
Storage Condition-20±5℃
Documentation
Documentation
-
Catalog No.OP-332
-
SMILESO=P(OCCC#N)(OC[C@H]1O[C@@H](N2C(N=CN=C3NC(C4=CC=CC=C4)=O)=C3N=C2)[C@H](OC)[C@@H]1OP(OCCC#N)(OC[C@H]5O[C@@H](N(C=N6)C7=C6C(NC(C8=CC=CC=C8)=O)=NC=N7)[C@H](OC)[C@@H]5OP(OCCC#N)N(C(C)C)C(C)C)=O)O[C@H]9[C@@H](OC)[C@H](N%10C(N=CN=C%11NC(C%12=CC=CC=C%12)=O)=C%11N=C%10)O[C@@H]9COC(C%13=CC=CC=C%13)(C%14=CC=C(OC)C=C%14)C%15=CC=C(OC)C=C%15
-
Molecular FormulaC90H96N19O22P3
-
Molecular Weight1888.7903
-
AppearanceWhite to off-white solid
-
PurityUPLC≥97%
-
Storage Condition-20±5℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
[2'-OMe-A(Bz)](pCyEt))[2'-OMe-A(Bz)-3'-CE-Phosphoramidite]](http://shop.hongene.com/cdn/shop/files/OP-332_V1_929967fc-bc42-43b4-a117-087c989f005b.jpg?v=1755668323&width=1214)